FluroTech (TEST.H.V) Azione Prezzo

FluroTech Ltd. engages in the commercialization of new technologies in the cannabis and hemp industries. The company is headquartered in Calgary, Alberta. The company went IPO on 2011-03-22. The firm is primarily focused on commercializing fluorescence spectroscopy technology in the pandemic defense sector. The Company, through its subsidiary, FluroTest Diagnostics Systems Ltd., is focused on commercializing a pandemic and emerging disease defense platform (PEDDP). FluroTest Diagnostics Systems Ltd. is a developer of diagnostics technology in high output rapid antigen testing for the detection of SARS-CoV-2 and other pathogens. Its FluroTest's system is designed for high-traffic pandemic environments including schools and colleges, hospitals and healthcare facilities, athletic stadiums and performance venues, airline and cruise ship terminals, corporate campuses, shopping centers, and manufacturing facilities, among others. The company provides test results using robotics automation, biochemistry, fluorescence detection and cloud computing.